Abstinence Rates with Office-based Buprenorphine Treatment Differ by Retention and Insurance Status
As office-based treatment of opioid dependence with buprenorphine becomes more widespread, an increasing number of reports describe practices and outcomes in real-world settings. This report describes a highly structured office-based program that included a 1–2 day inpatient induction, 5 weeks of 3-hour counseling sessions 4 times per week, then weekly counseling sessions for an additional 12 weeks. Participants attended subsequent monthly follow-up visits and were required to attend thrice weekly 12-step meetings. Full adherence was required to remain in the program. Among the 110 of 176 (63%) consecutively admitted patients available for follow-up at a minimum of 18 months,
- 85 patients (77%) reported continuous buprenorphine treatment.
- retained patients were more likely to report abstinence (p=0.01) and to be employed (p=0.03) than nonretained patients.
- retained patients with insurance were more likely to report abstinence than those without insurance (97% versus 86%, respectively) (p=0.04).